Clinical Trials and Similar Human Studies
Total hit(s): 97
S.No.
1
33987628
Inclusion of Cephalexin in COVID-19 Treatment Combinations May Prevent Lung Involvement in Mild Infections: A Case Report with Pharmacological Genomics Perspective
Glob Med Genet
2021 Jun
2
33942765
Plasma therapy in COVID-19: All that glitters is not gold
Lung India
2021 May-Jun
0.93
3
33956936
Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality
Clin Infect Dis
2021 May 6
7.71
4
33831737
A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers
J Pharm Biomed Anal
2021 May 30
5
33987794
The Association Between Convalescent Plasma Treatment and Survival of Patients with COVID-19
J Gen Intern Med
2021 May 13
2.39
6
33986543
Tocilizumab for the treatment of severe COVID-19
Nat Med
2021 May 13
22.66
7
33979511
Plasma Therapy to Prevent Severe Covid-19 in Older Adults. Reply
N Engl J Med
2021 May 12
37.91
8
33979509
Plasma Therapy to Prevent Severe Covid-19 in Older Adults
N Engl J Med
2021 May 12
37.91
9
33979510
Plasma Therapy to Prevent Severe Covid-19 in Older Adults
N Engl J Med
2021 May 12
37.91
10
33870492
CORRIGENDUM: Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Clin Pharmacol Ther
2021 May
5.26
11
33723852
COVID-19 convalescent plasma; time for ""goal directed therapy""?
Transfusion
2021 May
2.75
12
33839300
Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review
Transfus Clin Biol
2021 Apr 8
1.04
13
33848774
Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
Biomed Pharmacother
2021 Apr 6
3.83
14
33836277
Photodynamic therapy with curcumin for combating SARS-CoV-2
Photodiagnosis Photodyn Ther
2021 Apr 6
2.65
15
33818607
Tocilizumab in Treatment for Patients With COVID-19-Reply
JAMA Intern Med
2021 Apr 5
14.57
16
33818612
Tocilizumab in Treatment for Patients With COVID-19
JAMA Intern Med
2021 Apr 5
14.57
17
33818593
Tocilizumab in Treatment for Patients With COVID-19
JAMA Intern Med
2021 Apr 5
14.57
18
33818610
Tocilizumab in Treatment for Patients With COVID-19-Reply
JAMA Intern Med
2021 Apr 5
14.57
19
33818614
Tocilizumab in Treatment for Patients With COVID-19
JAMA Intern Med
2021 Apr 5
14.57
20
33913168
High-titer convalescent plasma therapy for COVID-19 and mortality
Transfusion
2021 Apr 28
2.75
21
33893187
REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19
J Nucl Med
2021 Apr 23
7.887
22
33887110
Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A retrospective observational study
Ther Apher Dial
2021 Apr 22
23
33931305
Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
Transfus Clin Biol
2021 Apr 20
1.04
24
33880453
Commentary: Therapeutic Plasma Exchange in COVID -19 pediatric patients: Is there a role?
JTCVS Tech
2021 Apr 16
4.31
25
33847265
COVID-19 and TEN treated with IVIG and Total plasma exchange. Simultaneous systemic treatment for both diseases
J Investig Allergol Clin Immunol
2021 Apr 13